SCHEMBL2184498

SCHEMBL2184498

CCCCCCCCCCC=CCN

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 6/20 0.58
TRPV1 Q8NER1 1/20 0.58
CYP1A2 P05177 2/20 0.56
CYP2C19 P33261 2/20 0.56
KMT2A Q03164 2/20 0.56
MEN1 O00255 1/20 0.56
TP53 P04637 1/20 0.56
CYP3A4 P08684 1/20 0.56
SOAT1 P35610 1/20 0.56
TERT O14746 3/20 0.50
PTPN1 P18031 3/20 0.50
MAPT P10636 2/20 0.50
BLM P54132 2/20 0.50
HSD17B10 Q99714 2/20 0.50
FABP4 P15090 2/20 0.50
PPARG P37231 2/20 0.50
PPARD Q03181 2/20 0.50
PPARA Q07869 2/20 0.50
GMNN O75496 1/20 0.50
USP2 O75604 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3455495 1.00 FAAH (0.58) FAAHTRPV1CYP1A2CYP2C19KMT2A
SCHEMBL2137537 1.00 FAAH (0.58) FAAHTRPV1CYP1A2CYP2C19KMT2A
SCHEMBL3128648 1.00 FAAH (0.58) FAAHTRPV1CYP1A2CYP2C19KMT2A
SCHEMBL9235251 1.00 FAAH (0.58) FAAHTRPV1CYP1A2CYP2C19KMT2A
SCHEMBL625642 1.00 FAAH (0.58) FAAHTRPV1CYP1A2CYP2C19KMT2A
SCHEMBL2137541 1.00 FAAH (0.58) FAAHTRPV1CYP1A2CYP2C19KMT2A
SCHEMBL3625233 1.00 FAAH (0.58) FAAHTRPV1CYP1A2CYP2C19KMT2A
SCHEMBL2184557 1.00 FAAH (0.58) FAAHTRPV1CYP1A2CYP2C19KMT2A
SCHEMBL3625235 1.00 FAAH (0.58) FAAHTRPV1CYP1A2CYP2C19KMT2A
SCHEMBL3623659 1.00 FAAH (0.58) FAAHTRPV1CYP1A2CYP2C19KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1189622-B1 ANIONIC POLYMERS AS TOXIN BINDERS AND ANTIBACTERIAL AGENTS GENZYME CORP (US) 2007-07-25 EP claimed
EP-1800687-A2 Anionic polymers as toxin binders and antibacterial agents GENZYME CORPORATION (US) 2007-06-27 EP claimed
EP-0915705-B1 IONIC POLYMERS AS ANTI-INFECTIVE AGENTS GENZYME CORP (US) 2007-01-10 EP claimed
US-6890523-B2 Anionic polymers as toxin binders and antibacterial agents GENZYME CORPORATION (US) 2005-05-10 US claimed
EP-1014999-B1 CATIONIC POLYMERS AS TOXIN-BINDING AGENTS GENZYME CORP (US) 2004-12-08 EP claimed
US-20030138397-A1 Anionic polymers as toxin binders and antibacterial agents GELTEX PHARMACEUTICALS, INC. 2003-07-24 US claimed
US-6593366-B2 Cationic quaternery ammonium containing polymers for treatment of gastrointestinal disorders; cytotoxicity GELTEX PHARMACEUTICALS, INC. 2003-07-15 US claimed
JP-2002544226-A 2002-12-24 JP claimed
US-20020114777-A1 Ionic polymers as anti-infective agents GELTEX PHARMACEUTICALS, INC. (US) 2002-08-22 US claimed
US-6395777-B2 ORGANONITROGEN POLYMERS GELTEX PHARMACEUTICALS, INC. 2002-05-28 US claimed
EP-1189622-A2 ANIONIC POLYMERS AS TOXIN BINDERS AND ANTIBACTERIAL AGENTS Geltex Pharmaceuticals, Inc. (US) 2002-03-27 EP claimed
US-20010053794-A1 Ionic polymers as anti-infective agents GENZYME CORPORATION 2001-12-20 US claimed
US-20010041171-A1 Anionic polymers as toxin binders GELTEX PHARMACEUTICALS, INC. (US) 2001-11-15 US claimed
US-6270755-B1 POLYMER COMPRISING PENDANT ACID FUNCTIONAL GROUPS OR A SALT THEREOF WITH A PHARMACEUTICALLY ACCEPTABLE CATION, SAID POLYMER COMPRISING NO ACID ANHYDRIDE GROUPS. GELTEX PHARMACEUTICALS, INC. 2001-08-07 US claimed
WO-2000069428-A2 ANIONIC POLYMERS AS TOXIN BINDERS AND ANTIBACTERIAL AGENTS GELTEX PHARMACEUTICALS, INC. (US) 2000-11-23 WO claimed
EP-1014999-A1 CATIONIC POLYMERS AS TOXIN-BINDING AGENTS GELTEX PHARMACEUTICALS, INC. (US) 2000-07-05 EP claimed
US-6007803-A ADMINISTERING TO MAMMAL A CATIONIC POLYMER TO INHIBIT PATHOGENIC TOXINS GELTEX PHARMACEUTICALS, INC. (US) 1999-12-28 US claimed
EP-0915705-A1 IONIC POLYMERS AS ANTI-INFECTIVE AGENTS GELTEX PHARMACEUTICALS, INC. (US) 1999-05-19 EP claimed
WO-1999015186-A1 CATIONIC POLYMERS AS TOXIN-BINDING AGENTS GELTEX PHARMACEUTICALS, INC. (US) 1999-04-01 WO claimed
WO-1997049413-A1 IONIC POLYMERS AS ANTI-INFECTIVE AGENTS GELTEX PHARMACEUTICALS, INC. (US) 1997-12-31 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010041171-A1 Anionic polymers as toxin binders PIGS, CD47, BTD FAAH 1749/4885TRPV1 2528/4885CYP1A2 4873/4885
US-20010053794-A1 Ionic polymers as anti-infective agents PAM, ARG1, PIGS FAAH 2440/4885TRPV1 910/4885CYP1A2 4823/4885
US-20020114777-A1 Ionic polymers as anti-infective agents PAM, ARG1, PIGS FAAH 2440/4885TRPV1 910/4885CYP1A2 4823/4885
US-20030138397-A1 Anionic polymers as toxin binders and antibacterial agents MSN, ANTXR2, PNKP FAAH 2469/4885TRPV1 2841/4885CYP1A2 4873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.